Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Pemigatinib

02 3Ponatinib

03 3Ponatinibhydroklorid

04 3Put It Away

05 1Retifanlimab

06 1Retifanlimab

07 1Ruxolitinib

08 2Ruxolitinib Phosphate

09 2Tafasitamab

10 1Tafasitamabum

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 26/03/2021

Application Number : 20191122000062

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 26/03/2021

Application Number : 20191122000048

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength :

Packaging :

Brand Name : Pemazyre

Approval Date : 26/03/2021

Application Number : 20191122000055

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

05

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 9mg

Packaging :

Brand Name : Pemazyre

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

06

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Brand Name : Pemazyre

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

07

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 13.5MG

Packaging :

Brand Name : Pemazyre

Approval Date : 2021-05-10

Application Number : 1211535005

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 4.5MG

Packaging :

Brand Name : Pemazyre

Approval Date : 2021-05-07

Application Number : 1211535001

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Brand Name : Pemazyre

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Pemazyre

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Tablet

Dosage Strength : 9MG

Packaging :

Brand Name : Pemazyre

Approval Date : 2021-05-07

Application Number : 1211535003

Regulatory Info : Authorized

Registration Country : Spain

blank

10

Brand Name : Iclusig

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Iclusig

arrow
Aus. Peptide Conference
Not Confirmed

Incyte Corporation

Dosage Form : Film Coated Tablet

Dosage Strength : 15MG

Packaging :

Brand Name : Iclusig

Approval Date : 2016-09-13

Application Number : 113839005

Regulatory Info : Authorized

Registration Country : Spain

blank